Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the hydrocortisone market size evolved in recent years?

The hydrocortisone industry has seen robust expansion in the past and is projected to increase from $1.52 billion in 2024 to $1.62 billion in 2025, with a compound annual growth rate (CAGR) of 6.7%. The surge in the historical phase can be tied back to an increase in skin conditions, a growing elderly population, improved accessibility and awareness, pharmaceutical sector development, and the expansion of emerging markets.

What are the predictions for the hydrocortisone market size in the coming years?

Projected to experience robust expansion in the upcoming years, the hydrocortisone market is set to surge to a size of $2.09 billion by 2029, with a compound annual growth rate (CAGR) of 6.5%. The anticipated growth during the forecast period is linked to advances in technology, an increase in over the counter (OTC) demand, investment in research and demand, rising disposable income, and broadened distribution channels. The forecasted period is also expected to highlight key trends such as an emphasis on natural ingredients, combined therapy methods, personalized medication regimens, products infused with hydrocortisone, and a focus on sustainability.

Get your hydrocortisone market report here!

https://www.thebusinessresearchcompany.com/report/hydrocortisone-global-market-report

What key factors are fueling the growth of the hydrocortisone market?

The escalating occurrence of inflammatory and autoimmune diseases is projected to fuel the expansion of the hydrocortisone market. Such disorders involve the immune system erroneously attacking the body’s tissues, leading to chronic inflammation and tissue damage. The augmented application of treatments for inflammatory and autoimmune diseases owes to the upward trend of these conditions and improvements in medical therapies. Hydrocortisone serves as a treatment in inflammatory and autoimmune diseases like severe asthma exacerbations, reducing airway inflammation and enhancing breathing promptly. Its administration is mainly intravenous during emergencies. For example, data released by the National Center for Health Statistics (NCHS), a health statistics agency based in the U.S., revealed that the rate of current asthma among adults aged 18 and above increased from 8.4% in 2021 to 8.7% in 2022. Moreover, instances of asthma in the past 12 months for adults in the same age bracket escalated from 3.3% in 2021 to 3.7% in 2022. Hence, the escalating incidence of inflammatory and autoimmune diseases is likely to spur the growth of the hydrocortisone market.

How is the global hydrocortisone market divided into key segments?

The hydrocortisone market covered in this report is segmented –

1) By Type: Cream, Injection, Tablet

2) By Route Of Administration: Parenteral, Oral, Topical

3) By Application: Adrenocortical Dysfunction, Adrenergic Syndrome, High Blood Calcium, Thyroiditis, Rheumatoid Arthritis, Dermatitis, Asthma And Chronic Obstructive Pulmonary Disease, Other Application

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Cream: Topical Hydrocortisone Cream (0.5%, 1%, 2.5%), Hydrocortisone Ointment

2) By Injection: Hydrocortisone Sodium Succinate Injection, Hydrocortisone Acetate Injection

3) By Tablet: Oral Hydrocortisone Tablets (5mg, 10mg, 20mg), Extended-Release Hydrocortisone Tablets

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16446&type=smp

Who are the key firms paving the way for growth in the hydrocortisone market?

Major companies operating in the hydrocortisone market are Pfizer Inc., Johnson & Johnson, Merck & Co Inc, AbbVie Inc., Bayer AG, Novartis AG, The Dow Chemical Company, GlaxoSmithKline plc (GSK), Viatris Inc., Solvay SA, Teva Pharmaceutical Industries Ltd., Alcon Inc, Sandoz International GmbH, Valeant Pharmaceuticals International Inc, Fresenius Kabi AG, Macleods Pharmaceuticals Limited, Sun Pharmaceutical Industries Ltd., Bausch & Lomb Incorporated, Hikma Pharmaceuticals PLC, Aspen Pharmacare Holdings Limited, Ivax Pharmaceuticals Inc, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Limited, Impax Laboratories LLC, Akorn Incorporated, Taro Pharmaceutical Industries Ltd, Lannett Company Inc, Salix Pharmaceuticals Inc

What emerging trends are influencing the growth of the hydrocortisone market?

Top firms in the hydrocortisone market are emphasizing the use of combination therapies, such as butyrate-infused lotions, to improve treatment effectiveness and expand their range of products. The cooperation of hydrocortisone and butyrate lotion potentially optimizes the management of skin conditions by capitalizing on hydrocortisone’s anti-inflammatory capacities in conjunction with butyrate’s immunomodulatory effects and potential to enhance skin barrier function. For example, in November 2023, J. Molner AS., a pharmaceutical company based in Estonia, introduced Hydrocortisone Butyrate Lotion, 0.1%, into the American market, indicating a significant step forward in its plan to develop a global platform for its pharmaceutical products. The recently launched lotion, intended for inflammatory skin conditions, signifies Molner’s dedication to extending its business territory internationally.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16446

What regions are contributing significantly to the growth of the hydrocortisone market?

North America was the largest region in the hydrocortisone market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hydrocortisone market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Hydro Electricity Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hydro-electricity-global-market-report

Green Hydrogen Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/green-hydrogen-global-market-report

Hydrogen Fuel Cells Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hydrogen-fuel-cells-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: